Electrical Stimulation to Enhance Peripheral Nerve Regeneration
Launched by UNIVERSITY OF ALBERTA · Mar 25, 2015
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
**Trial Summary: Electrical Stimulation to Enhance Peripheral Nerve Regeneration**
This clinical trial is studying the effects of electrical stimulation on healing damaged nerves in the arm, particularly those injuries that affect the brachial plexus, a network of nerves that helps control arm and hand movement. The main goal is to see if using electrical stimulation after surgery can improve hand function and help the injured nerves recover better. Researchers will measure how well patients can move their hands, feel pressure, and perform tasks before and after treatment. They will also use questionnaires to learn how patients feel about their symptoms.
To participate in this study, individuals must be between the ages of 65 and 74 and have suffered a severe nerve injury that has caused complete loss of nerve function. Patients with other nervous system conditions or those who cannot understand the study will not be eligible. Participants will be randomly assigned to either receive electrical stimulation or to a control group without this treatment. Everyone will be followed closely for two years to track their progress, with assessments every three months for the first year and then every six months in the second year. This research could lead to new, effective treatment options for individuals with serious nerve injuries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with severe injury to the brachial plexus causing complete denervation.
- Exclusion Criteria:
- • The presence of other neurologic conditions.
- • Cognitive compromise that renders the patients unable to understand and consent to the study.
- • Minors younger than the age of 18.
About University Of Alberta
The University of Alberta, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong commitment to scientific excellence and community health, the university facilitates cutting-edge research across various medical disciplines. Its interdisciplinary approach fosters collaboration among researchers, clinicians, and students, ensuring that clinical trials are designed and conducted with the utmost rigor and ethical standards. By leveraging its extensive resources and expertise, the University of Alberta aims to translate research findings into meaningful advancements in patient care and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edmonton, Alberta, Canada
Edmonton, Alberta, Canada
Patients applied
Trial Officials
Ming Chan, MB ChB
Principal Investigator
University of Alberta
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials